about
Application of faecal metabonomics on an experimental model of tubulointerstitial fibrosis by ultra performance liquid chromatography/high-sensitivity mass spectrometry with MS(E) data collection technique.Adjunctive treatment with moxonidine versus nitrendipine for hypertensive patients with advanced renal failure: a cost-effectiveness analysis.Pressure-induced renal injury in angiotensin II versus norepinephrine-induced hypertensive rats.A mild decrease of renal function is related to increased hemoglobin level during 5-year follow-up period.Inhibition of the soluble epoxide hydrolase promotes albuminuria in mice with progressive renal diseaseAn adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis.Hyperuricemia as a Predictive Marker for Progression of Nephrosclerosis: Clinical Assessment of Prognostic Factors in Biopsy-Proven Arterial/Arteriolar NephrosclerosisWhite blood cell count predicts the odds of kidney function decline in a Chinese community-based population.Measurement properties of patient-reported outcome measures (PROMs) used in adult patients with chronic kidney disease: A systematic reviewSerum metabonomics study of adenine-induced chronic renal failure in rats by ultra performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.Overlooked Risk for Chronic Kidney Disease after Leptospiral Infection: A Population-Based Survey and Epidemiological Cohort EvidenceAssociation of hsCRP, white blood cell count and ferritin with renal outcome in chronic kidney disease patients.A new apparatus for standardized rat kidney biopsy.β-Catenin-Dependent Signaling Pathway Contributes to Renal Fibrosis in Hypertensive Rats.Emerging drugs for renal failure.Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study.Hypertension, renal disease, and drug considerations.Diabetic nephropathy: the proteinuria hypothesis.Effect of chronic dementia caregiving and major transitions in the caregiving situation on kidney function: a longitudinal study.Renal disease in cardiovascular disorders: an underrecognized problem.Insights into the emerging cardiometabolic prevention and management of diabetes mellitus.Sleep disturbances as nontraditional risk factors for development and progression of CKD: review of the evidence.Interaction between GFR and risk factors for morbidity and mortality in African Americans with CKD.Treatment of diabetic nephropathy with Tripterygium wilfordii Hook F extract: a prospective, randomized, controlled clinical trialThe safety of rosuvastatin: effects on renal and hepatic function.Conservative Management of Chronic Renal Failure.Obstructive sleep apnea syndrome and chronic kidney disease: a new cardiorenal risk factor.Analyses of acute kidney injury biomarkers by ultra-high performance liquid chromatography with mass spectrometry.Inflammation and Progression of CKD: The CRIC Study.A rare complication of idiopathic membranous nephropathy: crescentic transformation.Effectiveness of antihypertensive treatment in chronic renal failure: to what extent and with which drugs do patients treated by nephrologists achieve the recommended blood pressure?Chemopreventive effect of five drugs on renal interstitial fibrosis induced by an aristolochic acid-containing Chinese herb in rats.Role of CXCR1 (CKR-1) in inflammation of experimental mesangioproliferative glomerulonephritis.Simple renal cysts in the solitary kidney: Are they innocent in adult patients?
P2860
Q30571181-020D02A7-E603-498E-ACB6-71B8DF56AD46Q33291468-F4B7F91A-BDC7-41AF-8F7C-FA45A0172854Q33614801-83F025B2-2F8F-4D0E-B3A4-E877AD034E58Q33639624-F1B15940-14F2-46BF-B69D-68A7B184C63EQ33652488-9CBA7187-79A4-48BB-9F87-01B1451E0158Q33663437-42AC5CCB-4550-4898-A547-B9D259D73066Q33752285-B1F43354-CB5E-47ED-9400-D9F144591CEDQ33776383-4556C9EA-3391-45BC-A1B6-5C5407CFA2F6Q33821915-CD61C313-AB65-43FB-A0AC-4FF80FF7A0EEQ34088508-5B759D35-A343-46C5-B997-7B33E62C028DQ34497536-6E3488AF-F96A-44E1-83F1-C02CE9142EE2Q34541172-842C341A-0722-46E7-9F78-94D23B696928Q34704401-7CDEEBDD-9279-486A-8A18-2DD0DC59E9AAQ35511052-9BB858BD-5C0A-4D35-B2B8-A9444F829B65Q35602657-9E369B7A-2EA2-4699-9AC3-7B2D110881C7Q35678048-2D0BDD49-FA2A-48B3-98F0-A382F8858A11Q35911422-CAEAE477-8D98-443B-B67B-A11FCAE7C00AQ36061335-FCEFCFE8-C85F-4985-952F-8D465C7A2386Q36062952-C8798D75-3FA7-4635-AE86-B1DBB35E2524Q36077720-06432B6B-6991-4F04-8BA2-0E83EEC6F3BAQ36283712-D711C683-8624-40D0-8FB6-545E83036D2CQ36288307-95DE458B-3D4A-41B3-92AE-908BC00AD164Q36492539-670C0A2B-B05A-4892-BBB3-1E3FF41BDE9CQ36897652-1926E16F-83AA-4EDB-BCE9-743CDB2F5B67Q36945023-273CDFCF-BE8A-474D-8876-365EE7143E97Q37039603-7B8CBFBC-32AF-4CAE-AF85-0679953E5D77Q38179027-A2687B06-DA07-40EE-84F4-117382FBE58FQ38595498-8241826F-477E-4920-9A26-A1B12D773B99Q41022591-9ADFED90-2CDE-44D8-ADCB-730CE4C57BEAQ43805473-DDCF966F-21A7-4CA5-B93D-CB18C9C20A47Q44787249-416A6F4D-ED91-4DA7-9CFF-76B81D3993A1Q45242406-CEEAA2C5-8485-4E4D-95CF-0E7D975B85DCQ53123645-321CA1B9-1F4C-4501-94B4-0655315CD19EQ53145933-72883A76-FCB1-47FB-8AF7-5C1548DB0F41
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Progression of chronic renal failure.
@ast
Progression of chronic renal failure.
@en
type
label
Progression of chronic renal failure.
@ast
Progression of chronic renal failure.
@en
prefLabel
Progression of chronic renal failure.
@ast
Progression of chronic renal failure.
@en
P1476
Progression of chronic renal failure.
@en
P2093
Henry T Yu
P304
P356
10.1001/ARCHINTE.163.12.1417
P407
P577
2003-06-01T00:00:00Z